Product
Mitoxantrone liposome + Azacitidine
1 clinical trial
1 indication
Indication
Angioimmunoblastic T-cell LymphomaClinical trial
A Phase Ib/II Clinical Study of Mitoxantrone Liposome and Azacitidine in the Treatment of Relapsed/Refractory Angioimmunoblastic T-cell LymphomaStatus: Recruiting, Estimated PCD: 2024-12-01